Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'T(15-17) TRANSLOCATION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 196 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dash, A; Gilliland, DG
      Molecular genetics of acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    2. Hauksdottir, H; Privalsky, ML
      DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia

      CELL GROWTH & DIFFERENTIATION
    3. Pandolfi, PP
      Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia

      HUMAN MOLECULAR GENETICS
    4. Pandolfi, PP
      In vivo analysis of the molecular genetics of acute promyelocytic leukemia

      ONCOGENE
    5. Tobal, K; Moore, H; Macheta, M; Yin, JAL
      Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RAR alpha transcripts with a sensitive competitive RT-PCR method

      LEUKEMIA
    6. Visani, G; Buonamici, S; Malagola, M; Isidori, A; Piccaluga, PP; Martinelli, G; Ottaviani, E; Grafone, T; Baccarani, M; Tura, S
      Pulsed ATRA as single therapy restores long-term remission in PML-RAR alpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study

      LEUKEMIA
    7. Gameiro, P; Vieira, S; Carrara, P; Silva, AL; Diamond, J; de Sousa, AB; Mehta, AB; Prentice, HG; Guimaraes, JE; Hoffbrand, AV; Foroni, L; Parreira, A
      The PML-RAR alpha transcript in long-term follow-up of acute promyelocyticleukemia patients

      HAEMATOLOGICA
    8. Torok, M; Etkin, LD
      Two B or not two B? Overview of the rapidly expanding B-box family of proteins

      DIFFERENTIATION
    9. Wu, WS; Vallian, S; Seto, E; Yang, WM; Edmondson, D; Roth, S; Chang, KS
      The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases

      MOLECULAR AND CELLULAR BIOLOGY
    10. Burmeister, T; Thiel, E
      Molecular genetics in acute and chronic leukemias

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    11. Jansen, JH; Lowenberg, B
      Acute promyelocytic leukemia with a PLZF-RAR alpha fusion protein

      SEMINARS IN HEMATOLOGY
    12. Boisvert, FM; Kruhlak, MJ; Box, AK; Hendzel, MJ; Bazett-Jones, DP
      The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body

      JOURNAL OF CELL BIOLOGY
    13. Jurcic, JG; Nimer, SD; Scheinberg, DA; DeBlasio, T; Warrell, RP; Miller, WH
      Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia

      BLOOD
    14. Douer, D
      Transcription therapy for acute promyelocytic leukaemia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    15. Jurcic, JG; DeBlasio, T; Dumont, L; Yao, TJ; Scheinberg, DA
      Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia

      CLINICAL CANCER RESEARCH
    16. Johnson, AC; Murphy, BA; Matelis, CM; Rubinstein, Y; Piebenga, EC; Akers, LM; Neta, G; Vinson, C; Birrer, M
      Activator protein-1 mediates induced but not basal epidermal growth factorreceptor gene expression

      MOLECULAR MEDICINE
    17. Hofmann, WK; Kell, WJ; Fenaux, P; Castaigne, S; Ganser, A; Chomienne, C; Burnett, R; Kowal, C; Hoelzer, D; Burnett, AK
      Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study

      LEUKEMIA
    18. Van der Weyden, L; Rakyan, V; Luttrell, BM; Morris, MB; Conigrave, AD
      Extracellular ATP couples to cAMP generation and granulocytic differentiation in human NB4 promyelocytic leukaemia cells

      IMMUNOLOGY AND CELL BIOLOGY
    19. Meyers, S; Hiebert, SW
      Alterations in subnuclear trafficking of nuclear regulatory factors in acute leukemia

      JOURNAL OF CELLULAR BIOCHEMISTRY
    20. Ruggero, D; Wang, ZG; Pandolfi, PP
      The puzzling multiple lives of PML and its role in the genesis of cancer

      BIOESSAYS
    21. Stock, AD; Dennis, TR; Spallone, PA
      Precise localization by microdissection/reverse ISH and FISH of the t(15;17)(q24;q21.1) chromosomal breakpoints associated with acute promyelocytic leukemia

      CANCER GENETICS AND CYTOGENETICS
    22. Boisvert, FM; Hendzel, MJ; Bazett-Jones, DP
      Promyelocytic leukemia (PML) nuclear bodies are protein structures that donot accumulate RNA

      JOURNAL OF CELL BIOLOGY
    23. Redner, RL; Chen, JD; Rush, EA; Li, H; Pollock, SL
      The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties

      BLOOD
    24. Kogan, SC; Hong, SH; Shultz, DB; Privalsky, ML; Bishop, JM
      Leukemia initiated by PMLRAR alpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable

      BLOOD
    25. Doucas, V
      The promyelocytic (PML) nuclear compartment and transcription control

      BIOCHEMICAL PHARMACOLOGY
    26. Behre, G; Zhang, P; Zhang, DE; Tenen, DG
      Analysis of the modulation of transcriptional activity in myelopoiesis andleukemogenesis

      METHODS-A COMPANION TO METHODS IN ENZYMOLOGY
    27. Arnould, C; Philippe, C; Bourdon, V; Gregoire, MJ; Berger, R; Jonveaux, P
      The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia

      HUMAN MOLECULAR GENETICS
    28. Koken, MHM; Daniel, MT; Gianni, M; Zelent, A; Licht, J; Buzyn, A; Minard, P; Degos, L; Varet, B; de The, H
      Retinoic acid, but not arsenic trioxide, degrades the PLZF/RAR alpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient

      ONCOGENE
    29. Kogan, SC; Bishop, JM
      Acute promyelocytic leukemia: from treatment to genetics and back

      ONCOGENE
    30. Hummel, JL; Wells, RA; Dube, ID; Licht, JD; Kamel-Reid, S
      Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia

      ONCOGENE
    31. Osman, Y; Takahashi, M; Zheng, Z; Toba, K; Liu, A; Furukawa, T; Narita, M; Aizawa, Y; Koike, T; Shibata, A
      Dendritic cells stimulate the expansion of PML-RAR alpha specific cytotoxic T-lymphocytes: Its applicability for antileukemia immunotherapy

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    32. Lin, RJ; Egan, DA; Evans, RM
      Molecular genetics of acute promyelocytic leukemia

      TRENDS IN GENETICS
    33. Doucas, V; Tini, M; Egan, DA; Evans, RM
      Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    34. Geller, RB; Dix, SP
      Oral chemotherapy agents in the treatment of leukaemia

      DRUGS
    35. Jansen, JH; de Ridder, MC; Geertsma, WMC; Erpelinck, CAJ; van Lom, K; Smit, EME; Slater, R; van der Reijden, BA; de Greef, GE; Sonneveld, P; Lowenberg, B
      Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor

      BLOOD
    36. Edwards, RH; Wasik, MA; Finan, J; Rodriguez, R; Moore, J; Kamoun, M; Rennert, H; Bird, J; Nowell, PC; Salhany, KE
      Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia

      AJCP. American journal of clinical pathology
    37. Hussey, CE; Lyon, E; Millson, A; Lay, MJ; Wittwer, CT; Segal, GH
      A rapid practical RT-PCR-based approach for the detection of the PML/RARalpha fusion transcript in acute promyelocytic leukemia

      AJCP. American journal of clinical pathology
    38. GABOLI M; GANDINI D; DELVA L; WANG ZG; PANDOLFI PP
      ACUTE PROMYELOCYTIC LEUKEMIA AS A MODEL FOR CROSS-TALK BETWEEN INTERFERON AND RETINOIC ACID PATHWAYS - FROM MOLECULAR-BIOLOGY TO CLINICAL-APPLICATIONS

      Leukemia & lymphoma
    39. NASONBURCHENAL K; TAKLE G; PACE U; FLYNN S; ALLOPENNA J; MARTIN P; GEORGE ST; GOLDBERG AR; DMITROVSKY E
      TARGETING THE PML RAR-ALPHA TRANSLOCATION PRODUCT TRIGGERS APOPTOSIS IN PROMYELOCYTIC LEUKEMIA-CELLS/

      Oncogene
    40. FAGIOLI M; ALCALAY M; TOMASSONI L; FERRUCCI PF; MENCARELLI A; RIGANELLI D; GRIGNANI F; POZZAN T; NICOLETTI I; GRIGNANI F; PELICCI PG
      COOPERATION BETWEEN THE RING-B2 AND COILED-COIL DOMAINS OF PML IS NECESSARY FOR ITS EFFECTS ON CELL-SURVIVAL(B1)

      Oncogene
    41. LE XF; VALLIAN S; MU ZM; HUNG MC; CHANG KS
      RECOMBINANT PML ADENOVIRUS SUPPRESSES GROWTH AND TUMORIGENICITY OF HUMAN BREAST-CANCER CELLS BY INDUCING G1 CELL-CYCLE ARREST AND APOPTOSIS

      Oncogene
    42. Pulsoni, A; Stazi, A; Cotichini, R; Allione, B; Cerri, R; Di Bona, E; Nosari, AM; Pagano, L; Recchia, A; Ribersani, M; Rocchi, L; Veneri, D; Visani, G; Mandelli, F; Mele, A
      Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia

      EUROPEAN JOURNAL OF HAEMATOLOGY
    43. TESTA U; GRIGNANI F; HASSAN HJ; ROGAIA D; MASCIULLI R; GELMETTI V; GUERRIERO R; MACIOCE G; LIBERATORE C; BARBERI T; MARIANI G; PELICCI PG; PESCHLE C
      TERMINAL MEGAKARYOCYTIC DIFFERENTIATION OF TF-1 CELLS IS INDUCED BY PHORBOL ESTERS AND THROMBOPOIETIN AND IS BLOCKED BY EXPRESSION OF PML RAR-ALPHA FUSION PROTEIN/

      Leukemia
    44. TONG JH; FANT X; DUPREZ E; BENOIT G; UPHOFF CC; DREXLER HG; PLA JC; LOFVENBERG E; LANOTTE M
      EXPRESSION PATTERNS OF THE JEM-1 GENE IN NORMAL AND TUMOR-CELLS - UBIQUITY CONTRASTING WITH A FAINT, BUT RETINOID-INDUCED, MESSENGER-RNA EXPRESSION IN PROMYELOCYTIC NB4 CELLS

      Leukemia
    45. ALCALAY M; TOMASSONI L; COLOMBO E; STOLDT S; GRIGNANI F; FAGIOLI M; SZEKELY L; HELIN K; PELICCI PG
      THE PROMYELOCYTIC LEUKEMIA GENE-PRODUCT (PML) FORMS STABLE COMPLEXES WITH THE RETINOBLASTOMA PROTEIN

      Molecular and cellular biology
    46. VALLIAN S; CHIN KV; CHANG KS
      THE PROMYELOCYTIC LEUKEMIA PROTEIN INTERACTS WITH SP1 AND INHIBITS ITS TRANSACTIVATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR PROMOTER

      Molecular and cellular biology (Print)
    47. WANG ZG; DELVA L; GABOLI M; RIVI R; GIORGIO M; CORDONCARDO C; GROSVELD F; PANDOLFI PP
      ROLE OF PML IN CELL-GROWTH AND THE RETINOIC ACID PATHWAY

      Science
    48. LAMORTE VJ; DYCK JA; OCHS RL; EVANS RM
      LOCALIZATION OF NASCENT RNA AND CREB BINDING-PROTEIN WITH THE PML-CONTAINING NUCLEAR-BODY

      Proceedings of the National Academy of Sciences of the United Statesof America
    49. DAY PM; RODEN RBS; LOWY DR; SCHILLER JT
      THE PAPILLOMAVIRUS MINOR CAPSID PROTEIN, L2, INDUCES LOCALIZATION OF THE MAJOR CAPSID PROTEIN, L1, AND THE VIRAL TRANSCRIPTION REPLICATION PROTEIN, E2, TO PML ONCOGENIC DOMAINS/

      Journal of virology
    50. CAO TY; DUPREZ E; BORDEN KLB; FREEMONT PS; ETKIN LD
      RET FINGER PROTEIN IS A NORMAL COMPONENT OF PML NUCLEAR-BODIES AND INTERACTS DIRECTLY WITH PML

      Journal of Cell Science
    51. IMAIZUMI M; SUZUKI H; YOSHINARI M; SATO A; SAITO T; SUGAWARA A; TSUCHIYA S; HATAE Y; FUJIMOTO T; KAKIZUKA A; KONNO T; IINUMA K
      MUTATIONS IN THE E-DOMAIN OF RAR-ALPHA PORTION OF THE PML RAR-ALPHA CHIMERIC GENE MAY CONFER CLINICAL RESISTANCE TO ALL-TRANS-RETINOIC ACIDIN ACUTE PROMYELOCYTIC LEUKEMIA/

      Blood
    52. LABRECQUE J; ALLAN D; CHAMBON P; ISCOVE NN; LOHNES D; HOANG T
      IMPAIRED GRANULOCYTIC DIFFERENTIATION IN-VITRO IN HEMATOPOIETIC-CELLSLACKING RETINOIC ACID RECEPTOR-ALPHA-1 AND RECEPTOR-GAMMA

      Blood
    53. SAMOSZUK MK; TYNAN W; SALLASH G; NASR S; MONCZAK Y; MILLER WH
      AN IMMUNOFLUORESCENT ASSAY FOR ACUTE PROMYELOCYTIC LEUKEMIA-CELLS

      AJCP. American journal of clinical pathology
    54. WELLS RA; CATZAVELOS C; KAMELREID S
      FUSION OF RETINOIC ACID RECEPTOR-ALPHA TO NUMA, THE NUCLEAR MITOTIC APPARATUS PROTEIN, BY A VARIANT TRANSLOCATION IN ACUTE PROMYELOCYTIC LEUKEMIA

      Nature genetics
    55. BIESALSKI HK
      BIOAVAILABILITY OF VITAMIN-A

      European journal of clinical nutrition
    56. SITTERLIN D; TIOLLAIS P; TRANSY C
      THE RAR-ALPHA-PLZF CHIMERA ASSOCIATED WITH ACUTE PROMYELOCYTIC LEUKEMIA HAS RETAINED A SEQUENCE-SPECIFIC DNA-BINDING DOMAIN

      Oncogene
    57. GOGINENI SK; SHAH HO; CHESTER M; LIN JH; GARRISON M; ALIDINA A; BAYANI E; VERMA RS
      VARIANT COMPLEX TRANSLOCATIONS INVOLVING CHROMOSOME-1, CHROMOSOME-9, CHROMOSOME-9, CHROMOSOME-15 AND CHROMOSOME-17 IN ACUTE PROMYELOCYTIC LEUKEMIA WITHOUT RAR-ALPHA PML GENE FUSION REARRANGEMENT/

      Leukemia
    58. KITAMURA K; KIYOI H; YOSHIDA H; SAITO H; OHNO R; NAOE T
      MUTANT AF-2 DOMAIN OF PML-RAR-ALPHA IN RETINOIC ACID-RESISTANT NB4 CELLS - DIFFERENTIATION-INDUCED BY RA IS TRIGGERED DIRECTLY THROUGH PML-RAR-ALPHA AND ITS DOWN-REGULATION IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    59. NASONBURCHENAL K; MAERZ W; ALBANELL J; ALLOPENNA J; MARTIN P; MOORE MAS; DMITROVSKY E
      COMMON DEFECTS OF DIFFERENT RETINOIC ACID-RESISTANT PROMYELOCYTIC LEUKEMIA-CELLS ARE PERSISTENT TELOMERASE ACTIVITY AND NUCLEAR-BODY DISORGANIZATION

      Differentiation
    60. SZOSTECKI C; GULDNER HH; WILL H
      AUTOANTIBODIES AGAINST NUCLEAR DOTS IN PRIMARY BILIARY-CIRRHOSIS

      Seminars in liver disease
    61. MU ZM; LE XF; VALLIAN S; GLASSMAN AB; CHANG KS
      STABLE OVEREXPRESSION OF PML ALTERS REGULATION OF CELL-CYCLE PROGRESSION IN HELA-CELLS

      Carcinogenesis
    62. BROWN D; KOGAN S; LAGASSE E; WEISSMAN I; ALCALAY M; PELICCI PG; ATWATER S; BISHOP JM
      A PMLRAR-ALPHA TRANSGENE INITIATES MURINE ACUTE PROMYELOCYTIC LEUKEMIA

      Proceedings of the National Academy of Sciences of the United Statesof America
    63. KOKEN MHM; REID A; QUIGNON F; CHELBIALIX MK; DAVIES JM; KABAROWSKI JHS; ZHU J; DONG S; CHEN SJ; CHEN Z; TAN CC; LICHT J; WAXMAN S; DETHE H; ZELENT A
      LEUKEMIA-ASSOCIATED RETINOIC ACID RECEPTOR-ALPHA FUSION PARTNERS, PMLAND PLZF, HETERODIMERIZE AND COLOCALIZE TO NUCLEAR-BODIES

      Proceedings of the National Academy of Sciences of the United Statesof America
    64. HONG SH; DAVID G; WONG CW; DEJEAN A; PRIVALSKY ML
      SMRT COREPRESSOR INTERACTS WITH PLZF AND WITH THE PML-RETINOIC ACID RECEPTOR-ALPHA (RAR-ALPHA) AND PLZF-RAR-ALPHA ONCOPROTEINS ASSOCIATED WITH ACUTE PROMYELOCYTIC LEUKEMIA

      Proceedings of the National Academy of Sciences of the United Statesof America
    65. HE LZ; TRIBIOLI C; RIVI R; PERUZZI D; PELICCI PG; SOARES V; CATTORETTI G; PANDOLFI PP
      ACUTE-LEUKEMIA WITH PROMYELOCYTIC FEATURES IN PML RAR-ALPHA TRANSGENIC MICE/

      Proceedings of the National Academy of Sciences of the United Statesof America
    66. KALANTRY S; DELVA L; GABOLI M; GANDINI D; GIORGIO M; HAWE N; HE LZ; PERUZZI D; RIVI R; TRIBIOLI C; WANG ZG; ZHANG H; PANDOLFI PP
      GENE REARRANGEMENTS IN THE MOLECULAR PATHOGENESIS OF ACUTE PROMYELOCYTIC LEUKEMIA

      Journal of cellular physiology
    67. STERNSDORF T; JENSEN K; WILL H
      EVIDENCE FOR COVALENT MODIFICATION OF THE NUCLEAR DOT-ASSOCIATED PROTEINS PML AND SP100 BY PIC1 SUMO-1/

      The Journal of cell biology
    68. STERNSDORF T; JENSEN K; ZUCHNER D; WILL H
      CELLULAR-LOCALIZATION, EXPRESSION, AND STRUCTURE OF THE NUCLEAR DOT PROTEIN-52

      The Journal of cell biology
    69. LI JY; ENGLISH MA; BALL HJ; YEYATI PL; WAXMAN S; LICHT JD
      SEQUENCE-SPECIFIC DNA-BINDING AND TRANSCRIPTIONAL REGULATION BY THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER PROTEIN

      The Journal of biological chemistry
    70. KAMEI H
      CYSTINE STARVATION INDUCES REVERSIBLE LARGE-BODY FORMATION FROM NUCLEAR-BODIES IN T24 CELLS

      Experimental cell research
    71. BROOKS SC; STURGILL R; CHOI J; YEN A
      AN RXR-SELECTIVE ANALOG ATTENUATES THE RAR-ALPHA-SELECTIVE ANALOG-INDUCED DIFFERENTIATION AND NON-G(1)-RESTRICTED GROWTH ARREST OF NB4 CELLS

      Experimental cell research
    72. CHIH DY; CHUMAKOV AM; PARK DJ; SILLA AG; KOEFFLER HP
      MODULATION OF MESSENGER-RNA EXPRESSION OF A NOVEL HUMAN MYELOID-SELECTIVE CCAAT ENHANCER BINDING-PROTEIN GENE (C/EBP-EPSILON)/

      Blood
    73. BENEDETTI L; LEVIN AA; SCICCHITANO BM; GRIGNANI F; ALLENBY G; DIVERIO D; LOCOCO F; AVVISATI G; RUTHARDT M; ADAMO S; PELICCI PG; NERVI C
      CHARACTERIZATION OF THE RETINOID-BINDING PROPERTIES OF THE MAJOR FUSION PRODUCTS PRESENT IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS

      Blood
    74. LI YP; ANDERSEN J; ZELENT A; RAO S; PAIETTA E; TALLMAN MS; WIERNIK PH; GALLAGHER RE
      RAR-ALPHA-1 RAR-ALPHA-2-PML MESSENGER-RNA EXPRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS - A MOLECULAR AND LABORATORY-CLINICAL CORRELATIVE STUDY/

      Blood
    75. GRISOLANO JL; WESSELSCHMIDT RL; PELICCI PG; LEY TJ
      ALTERED MYELOID DEVELOPMENT AND ACUTE-LEUKEMIA IN TRANSGENIC MICE EXPRESSING PML-RAR-ALPHA UNDER CONTROL OF CATHEPSIN-G REGULATORY SEQUENCES

      Blood
    76. CHEN Z; TONG JH; DONG S; ZHU J; WANG ZY; CHEN SJ
      RETINOIC ACID REGULATORY PATHWAYS, CHROMOSOMAL TRANSLOCATIONS, AND ACUTE PROMYELOCYTIC LEUKEMIA

      Genes, chromosomes & cancer
    77. VISANI G; MANFROI S; TOSI P; MARTINELLI G
      ALL-TRANS-RETINOIC ACID AND PSEUDOTUMOR CEREBRI

      Leukemia & lymphoma
    78. MU ZM; LE XF; GLASSMAN AB; CHANG KS
      THE BIOLOGIC FUNCTION OF PML AND ITS ROLE IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia & lymphoma
    79. DOUCAS V; ISHOV AM; ROMO A; JUGUILON H; WEITZMAN MD; EVANS RM; MAUL GG
      ADENOVIRUS REPLICATION IS COUPLED WITH THE DYNAMIC PROPERTIES OF THE PML NUCLEAR-STRUCTURE

      Genes & development
    80. KANE JR; HEAD DR; BALAZS L; HULSHOF MG; MOTRONI TA; RAIMONDI SC; CARROLL AJ; BEH FG; KRANCE RA; SHURTLEFF SA; DOWNING JR
      MOLECULAR ANALYSIS OF THE PML RAR-ALPHA CHIMERIC GENE IN PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA/

      Leukemia
    81. WELLS RA; HUMMEL JL; DEKOVEN A; ZIPURSKY A; KIRBY M; DUBE I; KAMELREID S
      A NEW VARIANT TRANSLOCATION IN ACUTE PROMYELOCYTIC LEUKEMIA - MOLECULAR CHARACTERIZATION AND CLINICAL CORRELATION

      Leukemia
    82. GRIMWADE D; HOWE K; LANGABEER S; BURNETT A; GOLDSTONE A; SOLOMON E
      MINIMAL RESIDUAL DISEASE DETECTION IN ACUTE PROMYELOCYTIC LEUKEMIA BYREVERSE-TRANSCRIPTASE PCR - EVALUATION OF PML-RAR-ALPHA AND RAR-ALPHA-PML ASSESSMENT IN PATIENTS WHO ULTIMATELY RELAPSE

      Leukemia
    83. SEALE J; DELVA L; RENESTO P; BALITRAND N; DOMBRET H; SCROBOHACI ML; DEGOS L; PAUL P; CHOMIENNE C
      ALL-TRANS-RETINOIC ACID RAPIDLY DECREASES CATHEPSIN-G SYNTHESIS AND MESSENGER-RNA EXPRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    84. MILLER WH
      DIFFERENTIATION THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA - CLINICAL AND MOLECULAR-FEATURES

      Cancer investigation
    85. DENNY CT
      GENE REARRANGEMENTS IN EWINGS-SARCOMA

      Cancer investigation
    86. PANDOLFI PP
      PML, PLZF AND NPM GENES IN THE MOLECULAR PATHOGENESIS OF ACUTE PROMYELOCYTIC LEUKEMIA

      Haematologica
    87. DOUCAS V; EVANS RM
      THE PML NUCLEAR COMPARTMENT AND CANCER

      Biochimica et biophysica acta, CR. Reviews on cancer
    88. HSU SL; LIN HM; CHOU CK
      SUPPRESSION OF THE TUMORIGENICITY OF HUMAN HEPATOMA HEP3B CELLS BY LONG-TERM RETINOIC ACID TREATMENT

      Cancer letters
    89. SCHMITT K; ZOUBEK A; SCHWARZ R; TULZER G; KOLLER E; KRIEGER O; LUTZ D; GADNER H
      ALL-TRANS-RETINOIC ACID AND SHOUT-TIME, HIGH-DOSE CYTARABINE IN 2 CHILDREN WITH ACUTE PROMYELOCYTIC LEUKEMIA

      Medical and pediatric oncology
    90. DONG S; ZHU J; REID A; STRUTT P; GUIDEZ F; ZHONG HJ; WANG ZY; LICHT J; WAXMAN S; CHOMIENNE C; CHEN Z; ZELENT A; CHEN SJ
      AMINO-TERMINAL PROTEIN-PROTEIN INTERACTION MOTIF (POZ-DOMAIN) IS RESPONSIBLE FOR ACTIVITIES OF THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER RETINOIC ACID RECEPTOR-ALPHA FUSION PROTEIN

      Proceedings of the National Academy of Sciences of the United Statesof America
    91. EARLY E; MOORE MAS; KAKIZUKA A; NASONBURCHENAL K; MARTIN P; EVANS RM; DMITROVSKY E
      TRANSGENIC EXPRESSION OF PML RAR-ALPHA IMPAIRS MYELOPOIESIS/

      Proceedings of the National Academy of Sciences of the United Statesof America
    92. GROTZINGER T; JENSEN K; WILL H
      THE INTERFERON (IFN)-STIMULATED GENE SP100 PROMOTER CONTAINS AN IFN-GAMMA ACTIVATION SITE AND AN IMPERFECT IFN-STIMULATED RESPONSE ELEMENT WHICH MEDIATE TYPE-I IFN INDUCIBILITY

      The Journal of biological chemistry
    93. LE XF; YANG P; CHANG KS
      ANALYSIS OF THE GROWTH AND TRANSFORMATION SUPPRESSOR DOMAINS OF PROMYELOCYTIC LEUKEMIA GENE, PML

      The Journal of biological chemistry
    94. ANDRE C; GUILLEMIN MC; ZHU J; KOKEN MHM; QUIGNON F; HERVE L; CHELBIALIX MK; DHUMEAUX D; WANG ZY; DEGOS L; CHEN Z; DETHE H
      THE PML AND PML RAR-ALPHA DOMAINS - FROM AUTOIMMUNITY TO MOLECULAR ONCOLOGY AND FROM RETINOIC ACID TO ARSENIC/

      Experimental cell research
    95. KAMEI H
      REVERSIBLE LARGE-BODY FORMATION FROM NUCLEAR-BODIES UPON AMINO ACID(S) STARVATION IN T24 CELLS

      Experimental cell research
    96. BHATIA M; KIRKLAND JB; MECKLINGGILL KA
      1,25-DIHYDROXYVITAMIN D-3 PRIMES ACUTE PROMYELOCYTIC CELLS FOR TPA-INDUCED MONOCYTIC DIFFERENTIATION THROUGH BOTH PKC AND TYROSINE PHOSPHORYLATION CASCADES

      Experimental cell research
    97. GROTZINGER T; STERNSDORF T; JENSEN K; WILL H
      INTERFERON-MODULATED EXPRESSION OF GENES ENCODING THE NUCLEAR-DOT-ASSOCIATED PROTEINS SP100 AND PROMYELOCYTIC LEUKEMIA PROTEIN (PML)

      European journal of biochemistry
    98. YOSHIDA H; KITAMURA K; TANAKA K; OMURA S; MIYAZAKI T; HACHIYA T; OHNO R; NAOE T
      ACCELERATED DEGRADATION OF PML-RETINOIC ACID RECEPTOR-ALPHA (PML-RARA) ONCOPROTEIN BY ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA - POSSIBLE ROLE OF THE PROTEASOME PATHWAY

      Cancer research
    99. DIBONA E; MONTALDI A; GUERCINI N; ROSSI V; LUCIANO A; BIONDI A; RODEGHIERO F
      A (15-17)-TRANSLOCATION NOT ASSOCIATED WITH ACUTE PROMYELOCYTIC LEUKEMIA

      British Journal of Haematology
    100. MAEDA Y; HORIUCHI F; MIYATAKE J; SONO H; TATSUMI Y; URASE F; IRIMAJIRI K; HORIUCHI A
      INHIBITION OF GROWTH AND INDUCTION OF APOPTOSIS BY ALL-TRANS-RETINOICACID IN LYMPHOID-CELL LINES TRANSFECTED WITH THE PML RAR-ALPHA FUSIONGENE/

      British Journal of Haematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/01/21 alle ore 04:26:36